PBI35 QUALITY-OF-LIFE OUTCOMES COMPARING THE PROPOSED BIOSIMILAR MSB11022 TO REFERENCE ADALIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CHRONIC PLAQUE-TYPE PSORIASIS
2019
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
2
Citations
NaN
KQI